In summary, we discovered a novel ALKBH5/RIG-I/IFNα axis that promotes tumor progression by escaping immune killing mediated by the m6A-dependent HNRNPC binding of DDX58 mRNA in HNSCC. The gene discussed is ALKBH5; the disease is head and neck squamous cell carcinoma.